<DOC>
	<DOCNO>NCT00959972</DOCNO>
	<brief_summary>The purpose study determine new drug , varenicline , smoke cessation effective standard nicotine replacement therapy aide currently use , `` patch '' among smoker hospitalize coronary heart disease .</brief_summary>
	<brief_title>Varenicline Versus Transdermal Nicotine Patch Smoking Cessation Patients With Coronary Heart Disease</brief_title>
	<detailed_description>Quitting smoke single effective intervention treatment reduce death rate patient coronary heart disease ( CHD ) smoke . At University Ottawa Heart Institute ( Ottawa , Canada ) , institutional program place ensure staff consistently identify document tobacco use status treatment offer every smoker admit Institute . Currently , nicotine replacement therapy ( NRT ) principal medication use program . Recently , new medication , varenicline , approve smoke cessation Canada . Varenicline appear effective medication cessation currently available . To date , publish study varenicline fund manufacturer publish study report well work smoker hospitalize heart disease . This study involve sixty current smoker hospitalize UOHI CHD . Consenting smoker randomly assign receive varenicline 12 week transdermal NRT 12 week . Participants also complete two-page questionnaire inquire smoke history previous attempt quit , level nicotine dependence , symptom nicotine withdrawal self-efficacy respect quit smoking . All participant receive identical in-hospital counseling , self-help material follow-up support . The nurse specialist also contact participant phone 3 , 14 , 30 50 day post-hospital discharge check patient 's smoking status , ass risk relapse , identify adverse event occur . The study follow participant 12 26 week post randomization ask smoking status ( biochemically confirm carbon monoxide monitor ) , adherence prescribed medication , self-efficacy respect quit smoking , nicotine withdrawal smoke cessation resource use post-discharge .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>smoke least 10 cigarettes/day month prior admission patient diagnose acute coronary syndrome ( include patient admit unstable angina acute myocardial infarction ) , elective percutaneous coronary intervention , coronary artery bypass surgery point time motivate stop smoking geographically available followup visit ( i.e. , live within 1 hour study centre ) use NRT , Zyban ( Wellbutrin ) , and/or Champix 72 hour serious cardiac arrhythmia ( e.g. , tachycardia ) , vasospastic disease ( e.g. , Buerger 's disease , Prinzmetal 's variant angina ) severe renal impairment dialysis unable read understand English patient pregnant breastfeeding plan become pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Varenicline</keyword>
	<keyword>transdermal nicotine patch</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>prevention</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>Smoking cessation</keyword>
</DOC>